ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Outcome measures"

  • Abstract Number: 1656 • ACR Convergence 2020

    Knee OA Outcomes in Patients with Severe Obesity Following Bariatric Surgery or Total Knee Arthroplasty

    Jonathan Samuels1, Stephen Zak2, Ran Schwarzkopf2, Christine Ren-Fielding3, Manish Parikh4, Alex McLawhorn5, James Browne6, Peter Hallowell7, Brian Irving8, Craig Wood9, Christopher Still9 and Peter Benotti9, 1NYU Langone, Rye Brook, NY, 2NYU Langone Health, New York, NY, 3NYU Langone Health, New YOrk, 4Bellevue Hospital, New York, NY, 5Hospital for Special Surgeyr, New York, 6University of Virginia, Charlottesville, VA, 7University of Virginia, Charlottesville, 8Louisiana State University, Baton Rouge,, LA, 9Obesity institute at Geisinger, Danville

    Background/Purpose: High body mass index (BMI, kg/m2) is a modifiable risk factor that has been associated with the development and progression of osteoarthritis (OA) and…
  • Abstract Number: 1890 • ACR Convergence 2020

    Daily Management of Patients with Axial Spondyloarthritis: Self-monitoring of Disease Activity with a Smartphone App Is Feasible – a Proof of Concept Study

    Uta Kiltz1, Robin Kempin1, Jutta Richter2, Anna Schlegel1, Xenofon Baraliakos1, Styliani Tsiami3, Ioana Andreica1, Bjoern Buehring4, David Kiefer1 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, Duesseldorf, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Velbert, Germany

    Background/Purpose: Assessment and monitoring of disease activity and functioning is of major importance for the course of axial spondyloarthritis (axSpA). This is equally important for…
  • Abstract Number: 0160 • ACR Convergence 2020

    Use of PROMIS29 Across Inflammatory Arthritis: Score Distributions and Impact of Contextual Factors

    Alexis Ogdie1, Kaleb Michaud2, Mark Hwang3, Sofia Pedro4 and Patricia Katz5, 1University of Pennsylvania, Philadelphia, PA, 2FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita, 3McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 4FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 5University of California, San Francisco, Novato, CA

    Background/Purpose: The Patient-Reported Outcome Measure Information System (PROMIS) includes a set of instruments developed to measure physical, mental and social health. PROMIS measures have been…
  • Abstract Number: 0324 • ACR Convergence 2020

    Comparative Responsiveness of Outcome Measures in Psoriatic Arthritis: Preparation for Pragmatic Trials

    Courtney Stull1, Soumya Reddy2, M. Elaine Husni3, Jose Scher4, Ethan Craig1, Jessica Walsh5 and Alexis Ogdie1, 1University of Pennsylvania, Philadelphia, PA, 2NYU School of Medicine, New York, NY, 3Cleveland Clinic, Cleveland, OH, 4NYU School of Medicine, New York City, 5University of Utah School of Medicine, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT

    Background/Purpose: Psoriatic arthritis (PsA) is a heterogeneous condition; this presents a challenge in how to best measure disease activity for all patients. While several outcome…
  • Abstract Number: 0727 • ACR Convergence 2020

    Hip Involvement Leads to Poor Outcome in Adulthood in Children with Enthesitis Related Arthritis (ERA) Category of Juvenile Idiopathic Arthritis (JIA)

    Naveen R1, Namita Mohindra1, Neeraj Jain1 and Amita Aggarwal2, 1Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Enthesitis related arthritis (ERA) is the commonest category of JIA seen in India and constitutes 30-40% of all JIA patients. There are many studies…
  • Abstract Number: 1157 • ACR Convergence 2020

    Health and Socioeconomic Outcomes in a Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Cohort Followed for a Median of Fifteen Years

    Sara Alehashemi1, Megha Garg2, Kim Johnson3, Kelly King4, Chris Zalewski4, Debbie Payne5, Adriana de Jesus6, Joseph Snow7, Wadih Zein5, M. Teresa Magone5, Rachel Bishop8, Carmen Brewer4, Jeff Kim4, Scott Paul9, John Butman10 and Raphaela Goldbach-Mansky11, 1Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Clarksville, MD, 2NIH/NIAID, Rochester, NY, 3NIH, NIAID, Bethesda, 4NIH, NIDCD, Bethesda, MD, 5NIH/NEI, Bethesda, MD, 6Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Silver Spring, MD, 7NIH, NIMH, Bethesda, MD, 8NIH, NEI, Bethesda, MD, 9NIH, CC/RMD, Bethesda, MD, 10NIH, CC/DRD, Bethesa, MD, 11Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Potomac, MD

    Background/Purpose: Patients (pts) with NOMID have systemic inflammation and organ damage such as sensorineural hearing loss, hydrocephalus, optic nerve atrophy and growth plate defects. IL-1 blocking…
  • Abstract Number: 1668 • ACR Convergence 2020

    Long-Term Outcomes in Children Born to Anti-Ro and/or Anti-La Positive Mothers

    Talia Diaz1, Daniela Dominguez2, Edgar Jaeggi3, Andrea Knight4, Carl A. Laskin5, Lawrence Ng6, Franklin Silverio1, Earl D. Silverman7 and Linda Hiraki8, 1Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 3Fetal Cardiac Program, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 5Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, Hospital for Sick Children, Toronto, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Translational Medicine, Research Institute, The Hospital for Sick Children, and Department of Paediatrics, University of Toronto., Toronto, ON, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, and Department of Paediatrics, University of Toronto., Toronto, ON, Canada

    Background/Purpose: Neonatal Lupus Erythematosus (NLE) is an acquired autoimmune disorder associated with the transplacental passage of maternal anti-Ro and/or anti-La antibodies. Previous studies have suggested…
  • Abstract Number: 1893 • ACR Convergence 2020

    Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

    Corinne Miceli-Richard1, Denis Poddubnyy2, Atul Deodhar3, Weibin Bao4, Craig Parman5, Brian Porter6 and Effie Pournara5, 1Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, 2Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Oregon Health & Science University, Portland, OR, 4Novartis Pharmaceuticals Corporation, East Hannover, 5Novartis Pharma AG, Basel, Switzerland, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Predicting outcomes early in the disease course in patients (pts) with ankylosing spondylitis (AS) is challenging, owing to heterogeneity of symptoms, varying disease severity,…
  • Abstract Number: 0167 • ACR Convergence 2020

    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program

    Jonathan Patterson1, Kirby Magid2, Dhiren Patel3 and Matt Allison3, 1Pack Health, Birmingham, AL, 2University of North Carolina at Charlotte, Charlotte, 3Pack Health, Birmingham

    Background/Purpose: The goal of this study was to examine whether cluster analysis could be used to identify homogeneous subgroups of engagement in RA patients enrolled…
  • Abstract Number: 0338 • ACR Convergence 2020

    Increased Risk of Lymphoproliferative Disorders in Psoriatic Arthritis

    Eugenia Chen1 and Maida Wong2, 1Department of Medicine, University of California Irvine, Orange, CA, 2Division of Rheumatology, Department of Medicine, VA Long Beach Healthcare System, Long Beach, CA

    Background/Purpose: Psoriatic arthritis (PsA) is a systemic inflammatory disease that involves musculoskeletal and skin manifestations. Such autoimmune disease has been associated with increased lymphoproliferative disease…
  • Abstract Number: 0728 • ACR Convergence 2020

    Clinical Outcomes of Juvenile Arthritis in Adulthood: A Systematic Review

    Lily Siok Hoon Lim1, Woo Jin Kim2, Yushi Wang2 and Kaien Gu3, 1University of Manitoba, Children's Hospital of Manitoba, Winnipeg, MB, Canada, 2University of Manitoba Max Rady College of Medicine, Winnipeg, MB, Canada, 3University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Juvenile arthritis (JA) is the most common pediatric rheumatic disease, with potentially permanent functional impacts on patients long after initial diagnosis. Little is known…
  • Abstract Number: 1164 • ACR Convergence 2020

    Frequency of Genetic Diagnosis in an Autoinflammatory Disease Natural History Protocol Cohort of Patients

    Katelin R. Honer1, Kim Johnson1, Gema Souto Adeva1, Gina Montealegre Sanchez2, Jenna Wade3, Jacob Mitchell1, Katherine Townsend3, Adriana de Jesus4 and Raphaela Goldbach-Mansky5, 1Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, MD, 2Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Rockville, MD, 3Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, 4Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Silver Spring, MD, 5Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Potomac, MD

    Background/Purpose: Monogenic autoinflammatory diseases (AID) are caused by innate immune dysregulation resulting in systemic inflammation and variable organ-specific clinical manifestations. The Translational Autoinflammatory Disease Section…
  • Abstract Number: 1696 • ACR Convergence 2020

    Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative

    Stephen Bender1, Michael Weinblatt2 and Daniel Duch1, 1FACTORx, Cherry Hill, NJ, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Medical claims data have been used since 2008 to measure the implementation of the diagnostic and referral strategies resulting from participation in RAPID® CME…
  • Abstract Number: 1899 • ACR Convergence 2020

    Life Expectancy a Swiss Cohort of Patients with Ankylosing Spondylitis: A 35-Year Follow-up Study

    Zhixiu Li1, Mohammad Khan2, Sjef van der Linden3, Peter Villiger4, Heinz Baumberger5, Hermine Zandwijk6, Matthew Brown7 and Muhammad Khan8, 1Queensland University of Technology (QUT), Translational Genomics Group, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Qld, Australia, Brisbane, Queensland, Australia, 2Kent State University, Kent, OH, 3Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Bern, Switzerland, Mortroux, Belgium, 4Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 5Retired, Flims, Tajikistan, 6Retired, Mortroux, Belgium, 7Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, 8Case Western Reserve University, Cleveland OH, Westlake, OH

    Background/Purpose: To investigate life expectancy of a Swiss cohort of patients with ankylosing spondylitis (AS) versus general population during 35 years of longitudinal follow up,…
  • Abstract Number: 0168 • ACR Convergence 2020

    Impact of Adalimumab (Humira) Therapy on Ocular Inflammation, Selected Health Care Resource Utilization, and Patient-Reported Outcomes in Patients with Active Non-infectious Intermediate, Posterior, or Panuveitis in Routine Clinical Practice

    Uwe Pleyer1, Salem Almutairi2, Conor Murphy3, Rola Hamam4, Karina Julian5, Shereen Hammad6, Orsolya Nagy7, Zohar Habot-Wilner8, Zsuzsanna Szepessy9, Yan Guex-Crosier10 and Sofia Androudi11, 1Charité Universitätsmedizin Berlin, Klinik für Augenheilkunde, Berlin, Germany, 2Al-Bahar Ophthalmology Center - Al-Sabah Hospital, Kuwait City, Kuwait, 3Royal Victoria Eye & Ear Hospital, Dublin, Ireland, 4American University of Beirut, Beirut, Lebanon, 5Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 6AbbVie Biopharmaceuticals GmbH, Dubai, United Arab Emirates, 7AbbVie Kft, Budapest, Hungary, 8Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel, 9Semmelweis University, Budapest, Hungary, 10Jules-Gonin Eye Hospital, Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland, 11University of Thessaly, Larissa, Greece

    Background/Purpose: VISUAL clinical trials demonstrated efficacy and safety of adalimumab (ADA) in patients with active and inactive non-infectious, intermediate, posterior, or panuveitis (NIIPPU).1-3 The purpose…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 49
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology